U.S. Life Sciences Stock News

NasdaqGS:JRVR
NasdaqGS:JRVRInsurance

James River Group Holdings (JRVR) Q4 Combined Ratio Below 100% Challenges Bearish Narratives

Q4 2025 headline results and trend set up James River Group Holdings (JRVR) has reported Q4 2025 revenue of US$167.7 million with EPS of US$0.66, anchored by net income from continuing operations of about US$30.2 million for the quarter. The company has seen revenue move from US$191.5 million in Q3 2024 to US$174.8 million in Q2 2025 and US$167.7 million in Q4 2025, while quarterly EPS has ranged from a loss of US$2.25 in Q4 2024 to a profit of US$0.66 in the latest period, as combined ratios...
NYSE:ESRT
NYSE:ESRTOffice REITs

Empire State Realty Trust (ESRT) Q4 FFO Per Share Holds At About US$0.22 Challenging Bearish Views

Empire State Realty Trust (ESRT) closed out FY 2025 with Q4 revenue of US$199.2 million and basic EPS of US$0.12, alongside funds from operations of US$59.0 million and FFO per share of US$0.22. The company reported revenue of US$197.6 million in Q4 2024 and US$199.2 million in Q4 2025, while basic EPS moved from US$0.07 to US$0.12 over the same period. Trailing 12 month net margin was 5.7% compared with 6.2% a year ago, and a sizeable one off gain of US$34.9 million affected recent earnings...
NasdaqGM:CERS
NasdaqGM:CERSMedical Equipment

Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative

Cerus (CERS) has just closed out FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.01, while trailing 12 month figures sit at US$206.1 million in revenue and a basic EPS loss of US$0.08. Over recent quarters the company has seen revenue move from US$50.8 million in Q4 2024 to US$43.2 million in Q1 2025, then to US$52.4 million in Q2, US$52.7 million in Q3 and US$57.8 million in Q4, with basic EPS losses ranging between US$0.00 and US$0.04 per share across the same...
NasdaqGS:NFBK
NasdaqGS:NFBKBanks

Northfield Bancorp (NFBK) One Off US$41m Loss Reshapes Earnings Narratives For FY 2025

Northfield Bancorp FY 2025 Earnings: One Off Loss Knocks Back Full Year Picture Northfield Bancorp (NFBK) closed out FY 2025 with Q4 total revenue of US$39.7 million and a basic EPS loss of US$0.69, capping off a trailing 12 month net income of US$0.8 million and EPS of roughly US$0.02 that reflects the impact of a large one off charge. Over the past few quarters, revenue has moved from US$29.3 million in Q3 FY 2024 to US$39.7 million in Q4 FY 2025, while quarterly EPS has swung from US$0.28...
NasdaqCM:NBBK
NasdaqCM:NBBKBanks

NB Bancorp (NBBK) Margin Surge Reinforces Bullish Earnings Narrative Despite Valuation Debate

NB Bancorp's FY 2025 Earnings Snapshot NB Bancorp (NBBK) has just closed out FY 2025 with fourth quarter total revenue of US$64.2 million and basic EPS of US$0.19, alongside quarterly net income of US$7.7 million. Over the past year, the bank has seen total revenue move from US$44.9 million in Q4 FY 2024 to US$64.2 million in Q4 FY 2025, while quarterly EPS shifted from US$0.40 to US$0.19. With trailing 12 month earnings growth reported at 350.6% and net profit margin running at 30.7% versus...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings (MARA) Q4 US$1.7b Loss Reinforces Bearish Profitability Narratives

MARA Holdings (MARA) has just closed out FY 2025 with fourth quarter revenue of US$202.3 million and basic EPS of a US$4.70 loss, capping a volatile year in which quarterly revenue moved between US$213.9 million and US$252.4 million while EPS ranged from a US$1.55 loss to a US$2.29 profit. Over the same stretch, trailing twelve month revenue sat at US$907.1 million with a net loss of US$1.3b, setting up a results season where the story is less about top line scale and more about how much...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Revenue Beats Highlight Rezdiffra Momentum And Investor Trade Offs

Madrigal Pharmaceuticals reported strong fourth quarter revenue, supported by demand for its new MASH therapy, Rezdiffra. Rezdiffra adoption is gaining traction in the commercial rollout, contributing to revenue that surpassed earlier expectations. Analysts have responded positively to the results, reflecting increased confidence in Madrigal’s commercial path for NasdaqGS:MDGL. Madrigal Pharmaceuticals, trading as NasdaqGS:MDGL, is drawing fresh attention after upbeat fourth quarter results...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Should LPL’s Simplicity Alliance and Mixed Quarter Results Prompt Strategy Rethink From LPLA Investors?

LPL Financial Holdings and Simplicity Group previously announced a partnership under which, from May 1, 2026, Simplicity will become LPL’s preferred Brokerage General Agency, integrating LPL’s internal insurance unit and expanding advisors’ access to advanced insurance technology, planning support, and protection solutions. At the same time, LPL’s strong but expectation-missing quarterly results, evolving regulatory backdrop, and continued advisor recruiting underscore how business execution...
NYSEAM:IE
NYSEAM:IEMetals and Mining

How Investors May Respond To Ivanhoe Electric (IE) Revenue Uptick And Narrower 2025 Net Loss

Ivanhoe Electric Inc. has reported its full-year 2025 results, with sales rising to US$3.24 million from US$2.90 million and the net loss narrowing to US$105.87 million from US$128.62 million, compared with 2024. The reduction in basic loss per share from continuing operations, to US$0.79 from US$1.07, points to improving cost and earnings efficiency even as the business remains loss-making. Next, we will examine how Ivanhoe Electric’s improved revenue and narrower net loss shape the...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

How Investors May Respond To Mercury Systems (MRCY) Amid Rising Focus On West Asia Defense Tensions

In recent days, Mercury Systems, a U.S.-based aerospace and defense technology company, saw increased investor attention as escalating tensions in West Asia drew focus to defense suppliers supporting advanced military capabilities. This development underscores how shifts in regional security risk can quickly spotlight companies providing embedded processing, electronic warfare, and sensor technologies that underpin modern defense systems. We’ll now examine how this heightened focus on...
NYSE:VOYA
NYSE:VOYADiversified Financial

Is Voya Financial (VOYA) Pricing Look Attractive After Recent Share Price Weakness?

If you are wondering whether Voya Financial's current share price reflects its true worth, this article will walk through the key numbers that matter for valuation. The stock last closed at US$67.61, with returns of 3.0% decline over 7 days, 11.8% decline over 30 days, 10.6% decline year to date, 0.2% decline over 1 year, 1.9% decline over 3 years, and 16.9% gain over 5 years, which gives you a mixed picture of recent and longer term performance. This piece was prompted to provide ongoing...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

A Look At Adaptive Biotechnologies (ADPT) Valuation As CEO Updates MRD Growth And Profitability Outlook

Adaptive Biotechnologies (ADPT) shares are back in focus after CEO Chad Robins outlined fresh expectations for MRD testing volumes and profitability, updating investors on growth initiatives and margin targets for the coming years. See our latest analysis for Adaptive Biotechnologies. At a share price of US$16.08, Adaptive Biotechnologies has seen a 13.1% 30 day share price decline and a 6.1% 90 day share price decline. However, its 1 year total shareholder return of 98% and 3 year total...
NYSE:BRCC
NYSE:BRCCFood

Black Rifle Coffee (BRCC) Loss Reinforces Concerns Over Cash Runway Despite Revenue Near US$400 Million

BRC (BRCC) has wrapped up FY 2025 with Q4 revenue of US$112.7 million, alongside a basic EPS loss of US$0.03 and a net income loss of US$3.2 million, setting a clear snapshot of where the business stands today. The company has seen quarterly revenue move from US$89.9 million in Q1 2025 to US$112.7 million in Q4 2025, while basic EPS has ranged from a loss of US$0.07 in Q2 2025 to a smaller loss of US$0.00 in Q3 2025. This gives investors a fuller view of how the top line and per share results...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

A Look At ICF International (ICFI) Valuation After Earnings And Revenue Miss On Federal Sector Weakness

ICF International stock: earnings miss, federal headwinds and a mixed near-term picture ICF International (ICFI) shares are back in focus after fourth quarter 2025 results came in below consensus on both earnings and revenue, as ongoing federal sector headwinds outweighed strength in commercial and non federal work. See our latest analysis for ICF International. The earnings miss and softer federal revenue backdrop appear to be weighing on sentiment. A 16.84% 1 month share price return...
NYSE:SEMR
NYSE:SEMRSoftware

Semrush Holdings (SEMR) Returns To EPS Loss In Q4 FY 2025 Challenging Bullish Margin Story

Semrush Holdings (SEMR) just posted its FY 2025 numbers with Q4 revenue of US$117.7 million and a basic EPS loss of US$0.07, alongside a full year trailing revenue line of US$443.6 million and a trailing basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move from US$97.4 million in Q3 FY 2024 to US$117.7 million in Q4 FY 2025. Basic EPS has shifted from a profit of US$0.02 in Q4 FY 2024 to a loss of US$0.07 in Q4 FY 2025, which highlights a situation where...
NasdaqGM:BEEP
NasdaqGM:BEEPCommercial Services

Mobile Infrastructure (BEEP) Widening Losses Challenge Bullish Earnings Recovery Narrative

Mobile Infrastructure (BEEP) FY 2025 Earnings Snapshot Mobile Infrastructure (BEEP) has wrapped up FY 2025 with Q4 total revenue of US$8.8 million and a basic EPS loss of US$0.19, alongside a net income loss of US$7.7 million, putting margins firmly in the red for the period. The company has seen quarterly revenue move between US$8.2 million and US$9.1 million over FY 2025, while basic EPS losses ranged from US$0.10 to US$0.19. Trailing twelve month figures show revenue of US$35.1 million...
NasdaqGM:QTRX
NasdaqGM:QTRXLife Sciences

Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative

Quanterix FY 2025 earnings snapshot Quanterix (QTRX) has reported fourth quarter FY 2025 revenue of US$43.9 million with a basic EPS loss of US$0.49, alongside trailing twelve month revenue of US$138.9 million and a basic EPS loss of US$2.51, setting a clear picture of scale and ongoing losses for investors watching the story. The company has seen quarterly revenue move from US$35.2 million in Q4 2024 to US$43.9 million in Q4 2025, while basic EPS losses widened from US$0.30 to US$0.49, so...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Hub Group (HUBG) Is Up 5.3% After Disclosing US$77M Accounting Error And Delaying 10-K Filing

In February 2026, Hub Group, Inc. disclosed a US$77.0 million accounting error tied to purchased transportation costs and accounts payable, leading to plans to restate several 2025 quarterly results and delay its Form 10-K filing with the SEC. Shortly after revealing the error, the company’s board still affirmed a quarterly cash dividend of US$0.125 per share as part of its previously announced US$0.50 per-share annual capital allocation program, underscoring management’s commitment to...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Assessing Nutanix (NTNX) Valuation After AMD AI Alliance And Stronger Earnings

Investor focus on Nutanix (NTNX) has intensified after the company paired a multi‑year AI infrastructure partnership and equity deal with AMD with fresh quarterly results showing higher revenue and net income versus the prior year. See our latest analysis for Nutanix. The AMD equity deal at a purchase price of US$36.26 now sits below the latest share price of US$40.70, after a 7 day share price return of 7.5% and a 90 day share price return decline of 14.23%. The 1 year total shareholder...
NYSE:AIV
NYSE:AIVResidential REITs

Apartment Investment And Management (AIV) Discontinued Ops Windfall Tests Bearish Narratives On Core Losses

Apartment Investment and Management (AIV) has posted its latest FY 2025 numbers with third quarter revenue at US$35.1 million and basic EPS at a US$0.71 loss, while trailing twelve month figures show revenue of US$210.9 million and basic EPS of a US$1.01 loss. Over the past few reported periods, revenue has moved between US$35.1 million and US$54.2 million a quarter, with basic EPS ranging from a loss of US$0.07 to a loss of US$1.07, giving investors a clear view of the pressure on margins...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Pharma (NAMS) Is Down 9.2% After CEO Share Sale And Shelf Filing News - Has The Bull Case Changed?

NewAmsterdam Pharma recently reported full-year 2025 results showing sales of US$22.5 million and a narrower net loss of US$203.82 million, while also filing a shelf registration to offer up to 5,719,966 common shares and confirming multiple March 2026 investor conference appearances. Shortly after these disclosures, CEO Michael H. Davidson sold 443,707 ordinary shares for roughly US$14.75 million, a sizable insider transaction that may shape investor perceptions of management’s confidence...
NasdaqGS:ADV
NasdaqGS:ADVMedia

Advantage Solutions (ADV) Returns To Quarterly Profit And Tests Longstanding Bearish Narratives

Advantage Solutions (ADV) just posted its FY 2025 third quarter numbers, with revenue at US$915.0 million and basic EPS of US$0.06, set against trailing 12 month revenue of about US$3.5 billion and a trailing basic EPS loss of US$0.75. The company has seen quarterly revenue move from US$873.7 million in Q2 2025 and US$892.3 million in Q4 2024 to the latest US$915.0 million figure. Basic EPS shifted from a loss of US$0.55 in Q4 2024 and US$0.17 in Q1 2025 to a small profit in the latest...
NYSE:BJ
NYSE:BJConsumer Retailing

BJ's Wholesale Club Expansion Tests Market Share And Profitability Story

BJ's Wholesale Club Holdings (NYSE:BJ) is reporting twelve straight quarters of market share gains alongside record profitability. The company is pushing into new territories, including Alabama and Texas, supported by its Fresh 2.0 initiative and growing e commerce activity. Recent performance in private label and digital offerings is adding to the operational momentum and supporting its expansion plans. BJ's Wholesale Club sits at an interesting point for investors, with the stock at...
NYSE:RJF
NYSE:RJFCapital Markets

Raymond James Tech And AI Investments Meet Record Revenues And Weak Momentum

Raymond James Financial (NYSE:RJF) reported record quarterly revenues, supported by strong adviser recruiting and client asset growth. Management highlighted significant investments in technology, including AI tools and mobile platform upgrades, as key drivers of recent performance. The company pointed to operational efficiencies from these digital tools as a factor in adviser adoption and client engagement. For investors watching NYSE:RJF, the latest report comes with the stock trading...